← European Medicine Shortage Tracker · all medicines
Ranibizumab currently has availability issues reported in 2 European registers: Italy, Sweden.
Shortage ATC — · also listed as: RANIBIZUMAB · data refreshed 7 August 2026
As of 7 August 2026, 2 of the 10 tracked registers list current availability issues for Ranibizumab, covering 2 affected product presentations. The longest-running open report was filed in Sweden on 2025-07-14 and has now been open for about 13 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage RIMMYRAH | 2026-07-06 | 2026-12-31 | Elevata richiesta Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Ximluci 10 mg/ml Injektionsvätska, lösning | 2025-07-14 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Ranibizumab in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | RIMMYRAH | Shortage | 2026-07-06 | 2026-12-31 | Elevata richiesta |
| 🇸🇪 SE | Ximluci 10 mg/ml Injektionsvätska, lösning | Shortage | 2025-07-14 | 2026-12-31 |
Yes. As of 7 August 2026, availability issues are reported in: Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Ranibizumab: AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ranibizumab — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ranibizumab/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ranibizumab availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ranibizumab/">Ranibizumab shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>